de Oliveira Alvim Rafael, Mourao-Junior Carlos Alberto, de Oliveira Camila Maciel, de Faria Lima Rerisson, Horimoto Andréa Roseli Vançan Russo, Hong Valéria Aparecida Costa, Bortolotto Luiz Aparecido, Krieger José Eduardo, Pereira Alexandre Costa
Laboratory of Genetics and Molecular Cardiology, Heart Institute (InCor), University of São Paulo Medical School, Av. Dr. Enéas de Carvalho Aguiar, 44 Cerqueira César, São Paulo, SP CEP 05403-000 Brazil.
Department of Physiology, Federal University of Juiz de Fora, Campus Universitário - Bairro Martelos, Juiz de Fora, Minas Gerais - MG CEP 36036-900 Brazil.
Diabetol Metab Syndr. 2015 Oct 6;7:86. doi: 10.1186/s13098-015-0082-8. eCollection 2015.
Increased arterial stiffness predicts morbidity and mortality, independently of other cardiovascular risk factors, and glycemic control impairments are related to higher vascular stiffness. The aim of this study was to evaluate the association between HbA1c levels and increased arterial stiffness in a Brazilian rural population.
For this study were selected 1675 individuals (both genders and aged over 18 years) resident in the municipality of Baependi, a city located in the Southeast of Brazil. HbA1c levels were determined by HPLC. Pulse wave velocity (PWV) was measured with a non-invasive automatic device (Complior).
HbA1c levels were associated with an increased PWV. This was more relevant for the third tertile of age. In addition, logistic regression multivariate model including age, blood pressure, gender, BMI and fasting glucose showed that the elevation of a single unit percentage of HbA1c represented an increase of 54 % in the odds of increased arterial stiffness [OR 1.54 (95 % CI 1.01-2.17)]. Both, HbA1c and fasting glucose showed higher discriminatory power in the risk assessment for increased arterial stiffness in the non-diabetic when compared to the diabetic group (AUC of HbA1c = 0.71 vs 0.57, p = 0.02; AUC of fasting glucose = 0.66 vs 0.45, p = 0.0007, respectively).
Our findings indicate that a increase in HbA1c levels is associated with increased arterial stiffness and that both, HbA1c and fasting glucose, presented higher discriminatory power in the risk assessment for increased arterial stiffness in the non-diabetic group as compared to diabetic individuals.
动脉僵硬度增加可预测发病率和死亡率,独立于其他心血管危险因素,且血糖控制受损与较高的血管僵硬度相关。本研究的目的是评估巴西农村人群中糖化血红蛋白(HbA1c)水平与动脉僵硬度增加之间的关联。
本研究选取了居住在巴西东南部城市巴彭迪市的1675名个体(年龄超过18岁,男女不限)。通过高效液相色谱法测定HbA1c水平。使用非侵入性自动装置(Complior)测量脉搏波速度(PWV)。
HbA1c水平与PWV增加相关。这在年龄的第三个三分位数中更为明显。此外,包括年龄、血压、性别、体重指数和空腹血糖的逻辑回归多变量模型显示,HbA1c每升高一个单位百分比,动脉僵硬度增加的几率就增加54% [比值比(OR)为1.54(95%置信区间为1.01 - 2.17)]。与糖尿病组相比,HbA1c和空腹血糖在非糖尿病患者动脉僵硬度增加的风险评估中均显示出更高的辨别力(HbA1c的曲线下面积为0.71对0.57,p = 0.02;空腹血糖的曲线下面积为0.66对0.45,p = 0.0007)。
我们的研究结果表明,HbA1c水平升高与动脉僵硬度增加相关,并且与糖尿病个体相比,HbA1c和空腹血糖在非糖尿病组动脉僵硬度增加的风险评估中均具有更高的辨别力。